Cause of death, by non-communicable diseases, ages 60+, female in Singapore
Singapore: Cause of death, by non-communicable diseases, ages 60+, female was 73.7% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, female in Singapore, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 60+.
Analysis
Singapore recorded 73.7% for cause of death, by non-communicable diseases, ages 60+, female in 2021.
That represents a change of down 2.0% on the previous year and down 2.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, female in Singapore peaked at 82.0% in 2000 and was at its lowest, 72.2%, in 2019.
That places Singapore 98th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 60+, female in Singapore, year by year
| Year | % of total female deaths ages 60+ | Change |
|---|---|---|
| 2000 | 82.0% | — |
| 2010 | 75.9% | -7.5% |
| 2015 | 72.7% | -4.2% |
| 2019 | 72.2% | -0.7% |
| 2020 | 75.2% | +4.2% |
| 2021 | 73.7% | -2.0% |
Singapore compared with similar countries
- Singapore's 73.7% is below the median for high income countries, which is 81.5%, 90% of the median. (58 countries reporting)
- Singapore's 73.7% is below the median for East Asia & Pacific, which is 79.8%, 92% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 82.0% | 82.0% | 82.0% | 1 |
| 2010s | 73.6% | 72.2% | 75.9% | 3 |
| 2020s | 74.5% | 73.7% | 75.2% | 2 |
Countries ranked near Singapore
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate 1.93 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0196 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.52 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, female in Singapore?
- Cause of death, by non-communicable diseases, ages 60+, female in Singapore was 73.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, female recorded in Singapore?
- The highest recorded value was 82.0% in 2000.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, female recorded in Singapore?
- The lowest recorded value was 72.2% in 2019.
- How does Singapore rank for cause of death, by non-communicable diseases, ages 60+, female?
- Singapore ranks 98th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, female rising or falling in Singapore?
- Over the last ten years it is down 2.9%. The long-run trend across the full record is falling.
- Where does this Singapore data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.